Cargando…
The isoquinoline PRL-295 increases the thermostability of Keap1 and disrupts its interaction with Nrf2
Transcription factor Nrf2 and its negative regulator Keap1 orchestrate a cytoprotective response against oxidative, metabolic, and inflammatory stress. Keap1 is a drug target, with several small molecules in drug development. Here, we show that the isoquinoline PRL-295 increased Keap1 thermostabilit...
Autores principales: | Dayalan Naidu, Sharadha, Suzuki, Takafumi, Dikovskaya, Dina, Knatko, Elena V., Higgins, Maureen, Sato, Miu, Novak, Miroslav, Villegas, José A., Moore, Terry W., Yamamoto, Masayuki, Dinkova-Kostova, Albena T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749459/ https://www.ncbi.nlm.nih.gov/pubmed/35036882 http://dx.doi.org/10.1016/j.isci.2021.103703 |
Ejemplares similares
-
Detection of thermal shift in cellular Keap1 by protein-protein interaction inhibitors using immunoblot- and fluorescence microplate-based assays
por: Dayalan Naidu, Sharadha, et al.
Publicado: (2022) -
KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease
por: Dayalan Naidu, Sharadha, et al.
Publicado: (2020) -
Phenyl Bis-Sulfonamide
Keap1-Nrf2 Protein–Protein
Interaction Inhibitors with an Alternative Binding Mode
por: Georgakopoulos, Nikolaos, et al.
Publicado: (2022) -
Pirin, an Nrf2-Regulated Protein, Is Overexpressed in Human Colorectal Tumors
por: Zhang, Ying, et al.
Publicado: (2022) -
Phenethyl Isothiocyanate, a Dual Activator of Transcription Factors NRF2 and HSF1
por: Dayalan Naidu, Sharadha, et al.
Publicado: (2018)